Saturn V Capital Management LP Diversified Active

Location: Austin, TX

CIK: 0001964437 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value: $198M (100.0% shares, 0.0% debt)

Holdings (21)

ASND ASCENDIS PHARMA A/S 15.7%

Value $31.06M Shares 199,264 Est. Cost $128.89 Unrealized —

IRON DISC MEDICINE INC 13.0%

Value $25.72M Shares 518,177 Est. Cost $47.97 Unrealized +15.9%

CGON CG ONCOLOGY INC 7.1%

Value $14.15M Shares 577,696 Est. Cost $34.95 Unrealized -19.5%

XENE XENON PHARMACEUTICALS INC 7.0%

Value $13.88M Shares 413,711 Est. Cost $40.60 Unrealized -6.5%

— MERUS N V 6.9%

Value $13.6M Shares 323,211 Est. Cost $35.99 Unrealized —

MLTX MOONLAKE IMMUNOTHERAPEUTICS 6.8%

Value $13.43M Shares 343,849 Est. Cost $47.43 Unrealized -9.2%

SNDX SYNDAX PHARMACEUTICALS INC 6.5%

Value $12.79M Shares 1,041,280 Est. Cost $18.17 Unrealized -22.4%

CELC CELCUITY INC 5.6%

Value $11.06M Shares 1,093,677 Est. Cost $16.26 Unrealized -30.4%

COGT COGENT BIOSCIENCES INC 4.5%

Value $8.865M Shares 1,480,020 Est. Cost $8.73 Unrealized -10.1%

PCVX VAXCYTE INC 4.4%

Value $8.771M Shares 232,295 Est. Cost $70.39 Unrealized +13.6%

AMLX AMYLYX PHARMACEUTICALS INC 4.3%

Value $8.59M Shares 2,426,436 Est. Cost $3.98 Unrealized -10.6%

ARGX ARGENX SE 4.1%

Value $8.204M Shares 13,862 Est. Cost $394.09 Unrealized —

CNTA CENTESSA PHARMACEUTICALS PLC 3.3%

Value $6.452M Shares 448,692 Est. Cost $14.38 Unrealized —

OCUL OCULAR THERAPEUTIX INC 2.2%

Value $4.385M Shares 598,191 Est. Cost $8.35 Unrealized -7.9%

CTNM CONTINEUM THERAPEUTICS INC 2.0%

Value $3.916M Shares 560,979 Est. Cost $15.90 Unrealized -42.8%

ABVX ABIVAX SA 1.7%

Value $3.456M Shares 552,926 Est. Cost $14.21 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 1.5%

Value $2.943M Shares 255,060 Est. Cost $7.51 Unrealized +35.9%

NAMS NEWAMSTERDAM PHARMA COMPANY 1.2%

Value $2.382M Shares 116,353 Est. Cost $21.38 Unrealized +4.0%

SLN SILENCE THERAPEUTICS PLC 1.0%

Value $2.066M Shares 732,463 Est. Cost $11.10 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 1.0%

Value $1.979M Shares 59,017 Est. Cost $18.62 Unrealized +100.6%

— INOZYME PHARMA INC 0.2%

Value $454K Shares 499,254 Est. Cost $4.59 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ASND	ASCENDIS PHARMA A/S	199,264	$31.06M	15.7%	$128.89	—	SPONSORED ADR	04351P101
IRON	DISC MEDICINE INC	518,177	$25.72M	13.0%	$47.97	+15.9%	COM	254604101
CGON	CG ONCOLOGY INC	577,696	$14.15M	7.1%	$34.95	-19.5%	COM	156944100
XENE	XENON PHARMACEUTICALS INC	413,711	$13.88M	7.0%	$40.60	-6.5%	COM	98420N105
—	MERUS N V	323,211	$13.6M	6.9%	$35.99	—	COM	N5749R100
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	343,849	$13.43M	6.8%	$47.43	-9.2%	CLASS A ORD	61559X104
SNDX	SYNDAX PHARMACEUTICALS INC	1,041,280	$12.79M	6.5%	$18.17	-22.4%	COM	87164F105
CELC	CELCUITY INC	1,093,677	$11.06M	5.6%	$16.26	-30.4%	COM	15102K100
COGT	COGENT BIOSCIENCES INC	1,480,020	$8.865M	4.5%	$8.73	-10.1%	COM	19240Q201
PCVX	VAXCYTE INC	232,295	$8.771M	4.4%	$70.39	+13.6%	COM	92243G108
AMLX	AMYLYX PHARMACEUTICALS INC	2,426,436	$8.59M	4.3%	$3.98	-10.6%	COM	03237H101
ARGX	ARGENX SE	13,862	$8.204M	4.1%	$394.09	—	SPONSORED ADR	04016X101
CNTA	CENTESSA PHARMACEUTICALS PLC	448,692	$6.452M	3.3%	$14.38	—	SPONSORED ADS	152309100
OCUL	OCULAR THERAPEUTIX INC	598,191	$4.385M	2.2%	$8.35	-7.9%	COM	67576A100
CTNM	CONTINEUM THERAPEUTICS INC	560,979	$3.916M	2.0%	$15.90	-42.8%	CL A	21217B100
ABVX	ABIVAX SA	552,926	$3.456M	1.7%	$14.21	—	SPONSORED ADS	00370M103
KALV	KALVISTA PHARMACEUTICALS INC	255,060	$2.943M	1.5%	$7.51	+35.9%	COM	483497103
NAMS	NEWAMSTERDAM PHARMA COMPANY	116,353	$2.382M	1.2%	$21.38	+4.0%	ORDINARY SHARES	N62509109
SLN	SILENCE THERAPEUTICS PLC	732,463	$2.066M	1.0%	$11.10	—	ADS	82686Q101
CRNX	CRINETICS PHARMACEUTICALS IN	59,017	$1.979M	1.0%	$18.62	+100.6%	COM	22663K107
—	INOZYME PHARMA INC	499,254	$454K	0.2%	$4.59	—	COM	45790W108